Open Access

Role of HDAC1 in the progression of gastric cancer and the correlation with lncRNAs

  • Authors:
    • Zhiqiang Yu
    • Jun Zeng
    • Hui Liu
    • Tian Wang
    • Ziqi Yu
    • Jianyong Chen
  • View Affiliations

  • Published online on: January 23, 2019     https://doi.org/10.3892/ol.2019.9962
  • Pages: 3296-3304
  • Copyright: © Yu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Gastric cancer (GC) is a common life‑threatening cancer type worldwide, with an increasing prevalence and a high rate of mortality. Due to limitations in clinical treatment, surgery has become the most efficient strategy for the treatment of GC. It is urgent to identify novel biomarkers, which are useful for the diagnosis of GC and for improving the survival rate of patients with GC. HDACs are multi‑functional proteins and are involved in regulating gene expression, cell proliferation and the epigenetic regulation. However, the precise role of HDACs in the progression of GC remains unknown. The present study demonstrated that HDAC1 is involved in the promotion of GC cell proliferation, possibly by upregulating the expression of the lncRNAs, BC01600 and AF116637, in the tissues of patients with GC. Abnormal expression profiles of lncRNAs were observed in the tissues of patients with GC. lncRNAs were analyzed in the GSE64951 and GSE19826 databases, and it was revealed that BC01600 and AF116637 were two typically upregulated lncRNAs. Furthermore, it was revealed that BC01600 and AF116637 are regulated by HDAC1, as evidenced by decreased expression of these two lncRNAs in HDAC1‑knockout SC‑M1 cell lines, and by reduced expression of HDAC1 in these two lncRNA‑knockout SC‑M1 cell lines. Silencing of HDAC1 decreased the proliferation and increased the apoptosis of SC‑M1 cell lines, but had no effect on the migration of the SC‑M1 cell lines. The present study provided evidence of the importance of HDAC1 in the progression of SC‑M1, and the association between HDAC1 and the expression of lncRNAs. The results of the present study indicated that HDAC1 may be a promising target for the clinical treatment of GC.
View Figures
View References

Related Articles

Journal Cover

March-2019
Volume 17 Issue 3

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Yu Z, Zeng J, Liu H, Wang T, Yu Z and Chen J: Role of HDAC1 in the progression of gastric cancer and the correlation with lncRNAs. Oncol Lett 17: 3296-3304, 2019
APA
Yu, Z., Zeng, J., Liu, H., Wang, T., Yu, Z., & Chen, J. (2019). Role of HDAC1 in the progression of gastric cancer and the correlation with lncRNAs. Oncology Letters, 17, 3296-3304. https://doi.org/10.3892/ol.2019.9962
MLA
Yu, Z., Zeng, J., Liu, H., Wang, T., Yu, Z., Chen, J."Role of HDAC1 in the progression of gastric cancer and the correlation with lncRNAs". Oncology Letters 17.3 (2019): 3296-3304.
Chicago
Yu, Z., Zeng, J., Liu, H., Wang, T., Yu, Z., Chen, J."Role of HDAC1 in the progression of gastric cancer and the correlation with lncRNAs". Oncology Letters 17, no. 3 (2019): 3296-3304. https://doi.org/10.3892/ol.2019.9962